PRESS RELEASE: Bristol-Myers Squibb to Webcast December 5 Business Update

Bristol-Myers Squibb to Webcast December 5 Business Update

NEW YORK, Nov. 28 -- Bristol-Myers Squibb Company will provide a business update to the investment community on Wednesday, December 5 from 1 p.m. to 5 p.m. (EST).

Investors and the general public are invited to listen to a live webcast of the meeting at http://www.bms.com/ir. A replay of the December 5 business update will also be made available at the same company website.

Bristol-Myers Squibb Company is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.

SOURCE: Bristol-Myers Squibb Company

CONTACT: Jeff Macdonald, Communications, +1-212-546-4824,
[email protected], or John Elicker, Investor Relations,
+1-212-546-3775, [email protected]

Web site: http://www.bms.com/

Suggested Articles

After delivering a "positive surprise" in December, Biogen is painting a fuller picture of its lupus drug.

A new CRISPR technique neutralizes SARS-CoV-2 by scrambling the virus' genetic code. It could prove useful for fighting other viruses, like influenza.

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.